MATAURO’s Cabaletta Bio CABA Stock Holding History

MATAURO’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$171K	Hold	55,108	–	–	0.02%	153
2026 Q1	$148K	Hold	55,108	–	–	0.02%	138
2025 Q4	$121K	Buy	+55,108	New	+$137K	0.02%	144

Other funds holding CABA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

MATAURO's CABA Position: Q2 2026 in Review

MATAURO held its Cabaletta Bio (CABA) position steady in Q2 2026 at 55,108 shares worth $171K. The position accounts for 0.02% of the portfolio, ranked #153.

MATAURO first reported a position in CABA in Q4 2025 and has held it in 3 quarters since. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

MATAURO held 55,108 shares of Cabaletta Bio worth $171K as of Q2 2026.
MATAURO left its Cabaletta Bio share count unchanged in Q2 2026.
Cabaletta Bio made up 0.02% of MATAURO's portfolio in Q2 2026, its #153 holding.
MATAURO first reported a position in Cabaletta Bio in Q4 2025 and has held it in 3 quarters since.
140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on MATAURO's 13F filing for Q2 2026, filed 21 Jul 2026.